March 1 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its consolidated net profit excluding minority interest fell to 29.4 million levs ($17.1 million/15.0 million euro) in 2018 from 40.0 million levs the year before, on the back of a rise in expenses.